We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · October 12, 2020

Plasma ACE2 and Risk of Death or Cardiometabolic Diseases

The Lancet

 

Additional Info

The Lancet
Plasma ACE2 and Risk of Death or Cardiometabolic Diseases: A Case-Cohort Analysis
Lancet 2020 Oct 03;[EPub Ahead of Print], S Narula, S Yusuf, M Chong, et al

Further Reading